Roche: Tecentriq Combined With Lurbinectedin Shows Survival Benefit In Extensive-Stage Small Cell Lung Cancer

Published on 06/03/2025 at 01:04

Reuters

This article is reserved for members

Unlock the article: REGISTER NOW!

100% Free Registration

Already a customer? Log In

Latest news about Roche Holding AG

Roche Holding AG, 2024 Earnings Call, Jan 30, 2025	12:51pm
Thermo Fisher acquires Sanofi's New Jersey manufacturing site	09:45am	RE
OraSure Technologies received takeover bid from industry entrepreneur, sources say	Jul. 14	RE
ROCHE HOLDINGS AG : JP Morgan remains a Sell rating	Jul. 14	ZD
ROCHE HOLDINGS AG : Buy rating from UBS	Jul. 10	ZD
Swiss Market Index Closes Higher; SGS Shares Down	Jul. 09	MT
ROCHE HOLDINGS AG : JP Morgan reaffirms its Sell rating	Jul. 09	ZD
Deutsche Bank Remains Cautious on Pharmaceutical Sector Ahead of Earnings Season	Jul. 08	FW
ROCHE HOLDINGS AG : Deutsche Bank gives a Sell rating	Jul. 08	ZD
European shares fall as banks, mining stocks losses weigh	Jul. 04	RE
Swiss Market Index Closes Flat; Drugmakers Gain on US-Swiss Trade Deal Talks	Jul. 04	MT
ROCHE HOLDINGS AG : Goldman Sachs reaffirms its Sell rating	Jul. 04	ZD
Roche's Lebanese Unit Renews Healthcare Collaboration with Universities	Jul. 03	MT
Berenberg Cuts Zealand Pharma's Price Target Amid Increased Competition	Jul. 01	MT
ROCHE HOLDINGS AG : UBS reaffirms its Buy rating	Jul. 01	ZD
Amgen says gastric cancer drug meets main goal in late-stage trial	Jun. 30	RE
Rakovina Therapeutics Inc. Highlights Strong H1 Progress and Unveils Strategic Priorities for H2 2025	Jun. 30	CI
ROCHE HOLDINGS AG : Receives a Sell rating from JP Morgan	Jun. 30	ZD
Roche Head of Pharma Research and Early Development to Retire	Jun. 30	DJ
Bayer Receives EU Approval for Extended Eylea Treatment Intervals	Jun. 27	DP
Roche Diagnostics, Egypt's UPA Partner to Advance Green Procurement in Healthcare	Jun. 26	MT
Roche Holding AG - Special Call	Jun. 23
Lineage Cell Therapeutics, Inc. Announces 36-Month Visual Acuity Results Featured at Clinical Trials at the Summit 2025	Jun. 23	CI
Roche: positive Phase I/II data in hemophilia A	Jun. 23
Roche's Hemophilia Drug Shows Hemostatic Normalization Potential in Early-stage Study	Jun. 23	MT

ROCHE HOLDING AG

Stock

ROG

CH0012032048

Market Closed - Swiss Exchange Other stock markets 11:30:17 2025-07-16 am EDT
256.20 ^CHF	+0.47%

More quotes

Chart

Duration

Period

ROG: Dynamic Chart

Income Statement and Estimates

More financial data

Analysis / Opinion

ROCHE HOLDING : 2025 starts with a beat; tariff-led correction an entry opportunity

Roche will invest $50bn in US over five years.

April 22, 2025 at 04:49 am EDT

Roche CEO 'Very Confident' on Outlook, Momentum

October 23, 2024 at 08:38 am EDT

Obesity: Roche joins the battle

December 04, 2023 at 10:48 am EST

More Strategies

Headlines

The Week's Biggest Mergers Unpacked

Diageo reshuffles its management team: Nik Jhangiani temporarily replaces Debra Crew

July 16, 2025 at 09:29 am EDT

How did Indonesia go from 32% to 19% customs tariffs?

July 16, 2025 at 09:23 am EDT

Rare earths: Apple joins the industrial front supported by the Pentagon

July 16, 2025 at 06:16 am EDT

Is Scott Bessent the ideal candidate to succeed Jerome Powell?

July 16, 2025 at 06:06 am EDT

Rio Tinto posts strongest iron ore output since 2018 amid executive shake-up

July 16, 2025 at 04:08 am EDT

What if we already knew the name of Apple's next CEO?

July 16, 2025 at 03:21 am EDT

A Scandinavian consortium acquires Dalata for EUR1.4bn

July 15, 2025 at 10:04 am EDT

Mexican tomatoes: Made in the USA or higher prices, the Trump dilemma

July 15, 2025 at 09:56 am EDT

Meta to spend hundreds of billions on data centers

July 15, 2025 at 07:00 am EDT

All our articles